0001209191-17-038905.txt : 20170609 0001209191-17-038905.hdr.sgml : 20170609 20170609163648 ACCESSION NUMBER: 0001209191-17-038905 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170607 FILED AS OF DATE: 20170609 DATE AS OF CHANGE: 20170609 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANTARES PHARMA, INC. CENTRAL INDEX KEY: 0001016169 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411350192 STATE OF INCORPORATION: DE FISCAL YEAR END: 1208 BUSINESS ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 BUSINESS PHONE: 609-359-3020 MAIL ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20060120 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20020520 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/ DATE OF NAME CHANGE: 20010604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powell Fred M CENTRAL INDEX KEY: 0001331339 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32302 FILM NUMBER: 17903397 MAIL ADDRESS: STREET 1: C/O BEJING MED-PHARM CORPORATION STREET 2: 600 W. GERMANTOWN PIKE, SUITE 400 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-07 0 0001016169 ANTARES PHARMA, INC. ATRS 0001331339 Powell Fred M C/O ANTARES PHARMA, INC. 100 PRINCETON STREET SOUTH, SUITE 300 EWING NJ 08628 0 1 0 0 Senior Vice President & CFO Common Stock 2017-06-07 4 A 0 101434 2.66 A 201434 D Stock Option (right to buy) 2.66 2017-06-07 4 A 0 217725 0.00 A 2027-06-07 Common Stock 217725 217725 D Represents grant of restricted stock units made under the 2008 Equity Compensation Plan. The shares vest in three equal annual installments. Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The options vest in equal quarterly installments over three years from the date of grant. /s/Keith Muckenhirn as attorney-in-fact for Fred Powell 2017-06-09